Systemic lupus erythematosus in Thai children: Clinicopathologic findings and outcome in 82 patients

Journal of the Medical Association of Thailand

Volumn 88, Issue SUPPL. 8, 2005, Pages

  Pattaragarn, Anirut ^a   Sumboonnanonda, Achra ^a   Parichatikanond, Paisal ^a   Supavekin, Suroj ^a   Suntornpoch, Vibul ^a   Vongjirad, Arun ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Azathioprine; Cyclophosphamide; Hypertension; Infection; Lupus nephritis; Methylprednisolone; Survival

Indexed keywords

ANTIHYPERTENSIVE AGENT; AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE;

ARTICLE; BONE INFECTION; BRAIN VASCULITIS; CARDIOVASCULAR DISEASE; CATARACT; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM INFECTION; CHILD; CHILDHOOD DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; CYTOPENIA; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; FOLLOW UP; GLAUCOMA; HEART FAILURE; HEMATURIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; LABORATORY TEST; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYOCARDITIS; NAUSEA; ONSET AGE; PROBABILITY; RESPIRATORY TRACT INFECTION; RISK FACTOR; SKIN BLOOD VESSEL; SKIN INFECTION; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; THAILAND; TREATMENT OUTCOME; URINARY TRACT INFECTION; VASCULITIS; VOMITING;

CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; SURVIVAL ANALYSIS; THAILAND;

EID: 31744447071     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Petty RE Cassidy JT. Systemic lupus erythematosus. In: Cassidy JT, Petty RE, editors. Textbook of pe-diatric rheumatology. Philadelphia: W.B. Saunders, 2001:260-322.
2. Bongu A, Chang E, Ramsey-Goldman R. Can morbidity and mortality of SLE be improved? Best Pract Res Clin Rheumatol 2002;16:313-32.
3. Fessler BJ. Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis. Best Pract Res Clin Rheumatol 2002; 16: 281-91.
4. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
5. Churg J, Berstein J, Glassock RJ. Lupus nephritis. In: Churg J, Berstein J, Glassock RJ, editors. Renal disease: classification and atlas of glomerular diseases. New York: Igaku-Shoin; 1995:151.
6. Cameron JS. Lupus nephritis in childhood and adolescence. Pediatr Nephrol 1994;8:230-49.
7. Bader-Meunier B, Armengaud JB, Haddad E, Salomon R, Deschenes G, Kone-Paut I, et al. Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study. J Pediatr 2005;146:648-53.
8. Font J, Cervera R, Espinosa G, Pallares L, Ramos-Casals M, Jimenez S, et al. Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 1998;57:456-9.
9. Tucker LB, Menon S, Schaller JG, Isenberg DA. Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 1995;34:866-72.
10. Klein-Gitelman M, Reiff A, Silverman ED. Systemic lupus erythematosus in childhood. Rheum Dis Clin North Am 2002;28:561-77, vi-vii.
11. th ed. Baltimore: Lippincott Williams and Wilkins; 2004:865-86.
12. Perfumo F, Martini A. Lupus nephritis in children. Lupus 2005;14:83-8.
13. Yang LY, Chen WP, Lin CY. Lupus nephritis in children-a review of 167 patients. Pediatrics 1994;94: 335-40.
14. Benseler SM, Silverman ED. Systemic lupus erythematosus. Pediatr Clin North Am 2005;52:443-67, vi.
15. Kasitanon N, Louthrenoo W, Sukitawut W, Vichainun R. Causes of death and prognostic factors in Thai patients with systemic lupus erythematosus. Asian Pac J Allergy Immunol 2002;20:85-91.
16. Wongchinsri J, Tantawichien T, Osiri M, Akkasilpa S, Deesomchok U. Infection in Thai patients with systemic lupus erythematosus: a review of hospitalized patients. J Med Assoc Thai 2002;85:S34-9.
17. Shayakul C, Ong-aj-yooth L, Chirawong P, Nimmannit S, Parichatikanond P, Laohapand T, et al. Lupus nephritis in Thailand: clinicopathologic findings and outcome in 569 patients. Am J Kidney Dis 1995;26:300-7.
18. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 1999;78:167-75.
19. McCurdy DK, Lehman TJ, Bernstein B, Hanson V, King KK, Nadorra R, et al. Lupus nephritis: prognostic factors in children. Pediatrics 1992;89:240-6.
20. Sumboonnanonda A, Vongjirad A, Suntornpoch V, Laohapand T, Parichatikanond P. Renal pathology and long-term outcome in childhood SLE. J Med Assoc Thai 1998;81:830-4.
21. Rush PJ, Baumal R, Shore A, Balfe JW, Schreiber M. Correlation of renal histology with outcome in children with lupus nephritis. Kidney Int 1986;29:1066-71.
22. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality. J Rheumatol 1995;22:1265-70.
23. Marini R, Costallat LT. Young age at onset, renal involvement, and arterial hypertension are of adverse prognostic significance in juvenile systemic lupus erythematosus. Rev Rhum Engl Ed 1999;66:303-9.
24. Brunner HI SE, To T, Bombardier C, Feldman BM. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum 2002;46:436-44.
25. Li Z, Chen L, Tao R, Fan X. Clinical and bacteriologic study of eighty-six patients with systemic lupus erythematosus complicated by infections. Chin Med J (Engl) 1998;111:913-6.
26. Mok CC, Mak A, Chu WP, To CH, Wong SN. Longterm survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups. Medicine (Baltimore) 2005;84:218-24.
27. Hernandez-Cruz B, Tapia N, Villa-Romero AR, Reyes E, Cardiel MH. Risk factors associated with mortality in systemic lupus erythematosus. A case-control study in a tertiary care center in Mexico City. Clin Exp Rheumatol 2001;19:395-401.
28. Kim WU, Min JK, Lee SH, Park SH, Cho CS, Kim HY. Causes of death in Korean patients with systemic lupus erythematosus: a single center retrospective study. Clin Exp Rheumatol 1999;17:539-45.
29. Janwityanuchit S, Totemchokchyakarn K, Krachangwongchai K, Vatanasuk M. Infection in systemic lupus erythematosus. J Med Assoc Thai 1993;76:542-8.
30. Hagelberg S, Lee Y, Bargman J, Mah G, Schneider R, Laskin C, et al. Longterm followup of childhood lupus nephritis. J Rheumatol 2002;29:2635-42.
31. Barbano G, Gusmano R, Damasio B, Alpigiani MG, Buoncompagni A, Gattorno M, et al. Childhood-onset lupus nephritis: a single-center experience of pulse intravenous cyclophosphamide therapy. J Nephrol 2002;15:123-9.
32. Lehman TJ, Onel K. Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus. J Pediatr 2000;136:243-7.
33. Tangnararatchakit K, Tapaneya-Olarn C, Tapaneya-Olarn W. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children. J Med Assoc Thai 1999;82:S104-10.
34. Vachvanichsanong P, Dissaneewate P, Winn T. Intravenous cyclophosphamide for lupus nephritis in Thai children. Scand J Rheumatol 2004;33:339-42.
35. Wang LC, Yang YH, Lu MY, Chiang BL. Retrospective analysis of the renal outcome of pediatric lupus nephritis. Clin Rheumatol 2004;23:318-23. Epub 2004 Jun 2.